Tetraphase Pharmaceuticals to Participate in Upcoming Investor Conferences
April 30 2019 - 7:00AM
Business Wire
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a
biopharmaceutical company focused on developing and commercializing
novel tetracyclines to treat serious and life-threatening
conditions, today announced that senior management will be
participating at the SunTrust Robinson Humphrey 5th Annual Life
Sciences Summit on Tuesday, May 7, 2019 at the Lotte New York
Palace Hotel in New York City. Guy Macdonald, President and Chief
Executive Officer of Tetraphase, will also present a corporate
overview at the UBS Global Healthcare Conference on Monday, May 20,
2019 at 1:30 p.m. ET at the Grant Hyatt Hotel in New York City.
A live audio webcast of the UBS Global Healthcare Conference
presentation will be available on the Company’s website at
https://tphase.gcs-web.com/events-presentations. The archived
presentation will be available for 30 days.
About Tetraphase Pharmaceuticals, Inc.
Tetraphase Pharmaceuticals, Inc., is a biopharmaceutical company
using its proprietary chemistry technology to create novel
tetracyclines for serious and life-threatening conditions,
including infections caused by many of the multidrug-resistant
bacteria highlighted as urgent public health threats by the World
Health Organization and the Centers for Disease Control and
Prevention. The Company has created more than 3,000 novel
tetracycline compounds using its proprietary technology platform.
Tetraphase's lead product XERAVATM is approved for the treatment of
complicated intra-abdominal infections by the U.S. Food and Drug
Administration and the European Medicines Agency. The Company’s
pipeline also includes TP-271 and TP-6076, which are in Phase 1
clinical trials, and TP-2846, which is in preclinical testing for
acute myeloid leukemia. Please visit www.tphase.com for more
company information.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190430005033/en/
Media and Investor Contact:Jennifer
Vierajviera@tphase.com617-600-7040
Tetraphase Pharmaceuticals (NASDAQ:TTPH)
Historical Stock Chart
From Mar 2024 to Apr 2024
Tetraphase Pharmaceuticals (NASDAQ:TTPH)
Historical Stock Chart
From Apr 2023 to Apr 2024